Simple Choices for a Greener Everyday Life
DIY Natural Sunscreen recipes need caution after 2026 FDA sunscreen changes on bemotrizinol, PABA, and ingredient safety. Continue reading DIY Natural Sunscreen After FDA Safety Updates
Natural Clean Labels can blur safety, sourcing, and cruelty-free signals. Learn how evidence can help you read beauty claims with care. Continue reading Natural Clean Labels Need Clearer Beauty Proof
MoCRA Ingredient Transparency shows what FDA cosmetic listings can clarify for natural beauty shoppers—and what labels still cannot prove. Continue reading MoCRA Ingredient Transparency for Natural Beauty
Hyaluronic acid has dominated hydrating skincare for years, but polyglutamic acid is attracting attention as a possible alternative. The debate over polyglutamic acid vs hyaluronic acid raises a practical question: does the newer ingredient deliver better moisture, or is its Continue reading Polyglutamic Acid vs. Hyaluronic Acid: Is the New Hydration Favorite Really Better?
Dietary Ingredient Rules may affect GRAS notices, NDI reviews, labels, and supplement questions consumers can raise with clinicians. Continue reading Dietary Ingredient Rules: Consumer Clarity
Ingredient transparency helps shoppers assess natural product claims, compare labels, and ask clearer questions before personal care choices. Continue reading Ingredient Transparency in Natural Products
Learn how Supplement Marketing To Minors changed after New York’s 2024 law, with cautious notes on labels, age checks, and clinician questions. Continue reading Supplement Marketing To Minors: Law Shifts
MoCRA Ingredient Transparency reshapes cosmetic product listings, ingredient records, and safety accountability. Learn what labels still cannot show. Continue reading MoCRA Ingredient Transparency for Product Listings
DIY Natural Sunscreens need caution after FDA ingredient updates. Learn what changed, why SPF testing matters, and what to ask a clinician. Continue reading DIY Natural Sunscreens After FDA Updates
Cruelty-free claims face legal risk when labels are broad, absolute, or inconsistent with market practices. Lessons from the JPMS case. Continue reading Cruelty-Free Claims After The JPMS Case